Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death (Q42441668)

31 October 2017

title

Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death (English)

1 reference

31 October 2017

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

1 reference

1 reference

31 October 2017

Andre Gehrz

1 reference

31 October 2017

Susanne Müerköster

1 reference

31 October 2017

Jens Vorndamm

1 reference

31 October 2017

Marie-Luise Kruse

1 reference

31 October 2017

Ulrich R Fölsch

1 reference

31 October 2017

Heiner Schäfer

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

31 October 2017

1 reference

31 October 2017

1 reference

31 October 2017

1 reference

31 October 2017

page(s)

3243-3251

1 reference

NFkappaB-dependent chemoresistance in solid tumors.

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Expression profiling of microdissected pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Expression of a multidrug resistance gene in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Aberrant rel/nfkb genes and activity in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

1 reference

7 January 2021

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Synthesis and function of 3-phosphorylated inositol lipids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206390

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206390

1 reference

Dimensions Publication ID

31 October 2017

1018566375

0 references

Fatcat ID

release_335wnwwn6ndmnak6mg67day3ti

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/335wnwwn6ndmnak6mg67day3ti

24 November 2022

mapped directly with Wikidata item

1 reference